BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Samsung Biologics Reports Third Quarter 2021 Financial Results

Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compa...

October 27, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

October 26, 2021 | News

BD launches its second center of excellence in flow cytometry for clinical research at CMC In India

The CoE at CMC Vellorewill help to push the bounds of clinical research, provide opportunities for knowledge exchange and conduct diagnosis with highe...

October 25, 2021 | News

Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site

I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...

October 25, 2021 | News

AstraZeneca launches Clinical Data and Insights division in India

The Clinical Data & Insights team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data expe...

October 20, 2021 | News

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

The Australian grant represents PMC-309's third global patent approval since it received grants from Russia in June 2021 and South...

October 20, 2021 | News

Merck and Eisai Receive Positive EU CHMP Opinions

Positive Opinion Granted for Advanced Renal Cell Carcinoma Based on Significant Progression-Free Survival (PFS), Overall Survival (OS) and Objective Respon...

October 18, 2021 | News

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

360biolabs®, the most comprehensive contract research organization in Australia and New Zealand, has now officially joined forces with BioAgilytix Labs...

October 14, 2021 | News

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...

October 13, 2021 | News

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

News Facts:- Fujitsu and the University of Tokyo Hospital validate the effectiveness of proprietary AI technology that uses electrocardiographic data...

October 11, 2021 | News

CPhI Report predicts record EBITDAs for CDMOs in 2022

Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantl...

September 28, 2021 | News

Samsung Biologics introduced its CDO process platform, S-Cellerate(TM), at BPI 2021

Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at t...

September 23, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

September 21, 2021 | News

WuXi Biologics Completes SARS-CoV-2 Protein Synthesis for BVX-0320 and CoviDTH

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), announced that CDMO's global partner WuXi Biologics has completed the syn...

September 15, 2021 | News

Stay Connected